NO934003L - Syklopeptider - Google Patents

Syklopeptider

Info

Publication number
NO934003L
NO934003L NO934003A NO934003A NO934003L NO 934003 L NO934003 L NO 934003L NO 934003 A NO934003 A NO 934003A NO 934003 A NO934003 A NO 934003A NO 934003 L NO934003 L NO 934003L
Authority
NO
Norway
Prior art keywords
asp
arg
ala
gly
denotes
Prior art date
Application number
NO934003A
Other languages
English (en)
Other versions
NO934003D0 (no
NO309864B1 (no
Inventor
Alfred Dr Jonczyk
Guenter Dr Hoelzemann
Brunhilde Dr Felding-Habermann
Friedrich Dr Rippmann
Guido Dr Melzer
Beate Diefenbach
Horst Prof Dr Kessler
Roland Haubner
Jochen Wermuth
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO934003D0 publication Critical patent/NO934003D0/no
Publication of NO934003L publication Critical patent/NO934003L/no
Publication of NO309864B1 publication Critical patent/NO309864B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO934003A 1992-11-06 1993-11-05 Syklopeptider, fremgangsmÕte for fremstilling derav, farmasøytiske preparater, fremgangsmÕte for fremstilling derav, samt anvendelse av forbindelsene til fremstilling av legemidler NO309864B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237456A DE4237456A1 (de) 1992-11-06 1992-11-06 Cyclopeptide

Publications (3)

Publication Number Publication Date
NO934003D0 NO934003D0 (no) 1993-11-05
NO934003L true NO934003L (no) 1994-05-09
NO309864B1 NO309864B1 (no) 2001-04-09

Family

ID=6472232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934003A NO309864B1 (no) 1992-11-06 1993-11-05 Syklopeptider, fremgangsmÕte for fremstilling derav, farmasøytiske preparater, fremgangsmÕte for fremstilling derav, samt anvendelse av forbindelsene til fremstilling av legemidler

Country Status (21)

Country Link
EP (1) EP0596350B1 (no)
JP (1) JP3681764B2 (no)
KR (1) KR100238894B1 (no)
CN (1) CN1038751C (no)
AT (1) ATE154037T1 (no)
AU (1) AU666586B2 (no)
CA (1) CA2102447C (no)
CZ (1) CZ286170B6 (no)
DE (2) DE4237456A1 (no)
DK (1) DK0596350T3 (no)
ES (1) ES2105041T3 (no)
GR (1) GR3024550T3 (no)
HU (1) HU215600B (no)
MX (1) MX9306885A (no)
NO (1) NO309864B1 (no)
PL (1) PL177772B1 (no)
RU (1) RU2129563C1 (no)
SK (1) SK280597B6 (no)
TW (1) TW340849B (no)
UA (1) UA43822C2 (no)
ZA (1) ZA938281B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11975041B2 (en) * 2017-11-20 2024-05-07 Novmetapharma Co., Ltd. Composition comprising CHP (cyclo-his pro) for preventing, improving or treating of bone loss related disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents

Also Published As

Publication number Publication date
PL177772B1 (pl) 2000-01-31
SK280597B6 (sk) 2000-04-10
EP0596350A1 (de) 1994-05-11
RU2129563C1 (ru) 1999-04-27
PL300935A1 (en) 1994-05-16
JP3681764B2 (ja) 2005-08-10
KR940011479A (ko) 1994-06-21
TW340849B (en) 1998-09-21
ES2105041T3 (es) 1997-10-16
DE4237456A1 (de) 1994-05-11
ATE154037T1 (de) 1997-06-15
NO934003D0 (no) 1993-11-05
GR3024550T3 (en) 1997-12-31
EP0596350B1 (de) 1997-06-04
UA43822C2 (uk) 2002-01-15
AU5039993A (en) 1994-05-19
CZ286170B6 (cs) 2000-02-16
NO309864B1 (no) 2001-04-09
SK121793A3 (en) 1995-06-07
HU215600B (hu) 1999-01-28
AU666586B2 (en) 1996-02-15
CA2102447C (en) 2007-04-10
HUT68321A (en) 1995-06-28
DK0596350T3 (da) 1997-12-29
CN1093090A (zh) 1994-10-05
KR100238894B1 (ko) 2000-01-15
CZ235293A3 (en) 1994-07-13
CA2102447A1 (en) 1994-05-07
CN1038751C (zh) 1998-06-17
DE59306654D1 (de) 1997-07-10
MX9306885A (es) 1995-01-31
ZA938281B (en) 1994-06-07
JPH0892282A (ja) 1996-04-09

Similar Documents

Publication Publication Date Title
CA2120303A1 (en) Cyclic adhesion inhibitors
ES2144179T3 (es) Inhibidores de adhesion ciclicos.
NZ248377A (en) Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE251140T1 (de) N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
UA41355C2 (uk) Засіб для лікування нейро-сніду
DE69936381D1 (de) Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie
CA2148194A1 (en) Cyclopeptides of the formula i
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
DE3852935D1 (de) Substituierte Alpha-Aminosäuren mit pharmazeutischer Aktivität.
NO941151L (no) Lineære adhesjonsinhibitorer
ES2105041T3 (es) Ciclopeptidos.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
EP0248231A3 (en) Pharmacologically active peptides
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen